CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases
Estimated time to complete activity: 1 hour 30 minutes
Compatible with all modern internet browsers and mobile devices
EDUCATIONAL OBJECTIVES
Review the development of CAR T-cells up to the present day
Understand the implementation of CAR T-cells in the treatment of autoimmune diseases
Assess the risks, reservations, opportunities, and future potential of CAR T in autoimmune diseases
TARGET AUDIENCE
This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved or interested in CAR T-cell therapy for treating patients with inflammatory diseases.
PROGRAMME OVERVIEW
In this webinar, CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases, experts discuss the development of CAR T-cell therapy in oncology, including next-generation CARs. The application of CAR T to autoimmune diseases is then highlighted, alongside the potential risks and reservations associated with this therapeutic approach. This is followed by an interactive Q&A session between the audience and our panel of industry experts.
DISCLOSURE OF CONFLICTS OF INTEREST
CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.
Modules
Title | Presenters | Video | Questions |
CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases |
Professor Iain McInnes Professor Carl June Professor Georg Schett Professor Richard Furie |
1 hour 32 minutes |